Abstract
Operant behavior paradigms are essential in preclinical models of neuropsychiatric disorders, such as substance use disorders, enabling the study of complex behaviors including learning, salience, motivation, and preference. These tasks often involve repeated, time-resolved interactions over extended periods, producing large behavioral datasets with rich temporal structure. To support genome-wide association studies (GWAS), the Preclinical Addiction Research Consortium (PARC) has phenotyped over 3000 rats for oxycodone and cocaine addiction-like behaviors using extended access self-administration, producing over 100,000 data files. To manage, store, and process this data efficiently, we leveraged Dropbox, Microsoft Azure Cloud Services, and other widely available computational tools to develop a robust, automated data processing pipeline. Raw MedPC operant output files are automatically converted into structured Excel files using custom scripts, then integrated with standardized experimental, behavioral, and metadata spreadsheets, all uploaded from Dropbox into a relational SQL database on Azure. The pipeline enables automated quality control, data backups, daily summary reports, and interactive visualizations. This approach has dramatically improved PARC’s high-throughput phenotyping capabilities by reducing human workload and error, while improving data quality, richness, and accessibility. We here share our approach, as these streamlined workflows can deliver benefits to operant studies of any scale, supporting more efficient, transparent, reproducible, and collaborative preclinical research.
To uncover why some individuals are more vulnerable to addiction, the PARC rat GWAS and Biobank projects are testing thousands of rats, generating hundreds of thousands of behavioral data files. We created an automated system using Dropbox and Microsoft Azure to organize, store, and visualize these data. This pipeline reduces errors, saves time, and improves sharing, enabling large-scale, high-quality behavioral studies in preclinical models.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Psychiatry, University of California - San Diego, 92093, La Jolla, CA, USA (ROR: https://ror.org/0168r3w48) (GRID: grid.266100.3) (ISNI: 0000 0001 2107 4242)




